Laboratory for Molecular Pharmacology, Department of Neuroscience and Pharmacology, the Panum Institute, Copenhagen, Denmark.
J Biol Chem. 2012 Dec 21;287(52):43516-26. doi: 10.1074/jbc.M112.395137. Epub 2012 Nov 7.
In seven-transmembrane (7TM), G protein-coupled receptors, highly conserved residues function as microswitches, which alternate between different conformations and interaction partners in an extended allosteric interface between the transmembrane segments performing the large scale conformational changes upon receptor activation. Computational analysis using x-ray structures of the β(2)-adrenergic receptor demonstrated that PheVI:09 (6.44), which in the inactive state is locked between the backbone and two hydrophobic residues in transmembrane (TM)-III, upon activation slides ∼2 Å toward TM-V into a tight pocket generated by five hydrophobic residues protruding from TM-III and TM-V. Of these, the residue in position III:16 (3.40) (often an Ile or Val) appears to function as a barrier or gate for the transition between inactive and active conformation. Mutational analysis showed that PheVI:09 is essential for the constitutive and/or agonist-induced signaling of the ghrelin receptor, GPR119, the β(2)-adrenergic receptor, and the neurokinin-1 receptor. Substitution of the residues constituting the hydrophobic pocket between TM-III and TM-V in the ghrelin receptor in four of five positions impaired receptor signaling. In GPR39, representing the 12% of 7TM receptors lacking an aromatic residue at position VI:09, unchanged agonist-induced signaling was observed upon Ala substitution of LeuVI:09 despite reduced cell surface expression of the mutant receptor. It is concluded that PheVI:09 constitutes an aromatic microswitch that stabilizes the active, outward tilted conformation of TM-VI relative to TM-III by sliding into a tight hydrophobic pocket between TM-III and TM-V and that the hydrophobic residue in position III:16 constitutes a gate for this transition.
在七跨膜(7TM)G 蛋白偶联受体中,高度保守的残基充当微开关,在跨膜片段之间的扩展变构界面中,这些微开关在不同构象和相互作用伴侣之间交替,从而在受体激活时执行大规模构象变化。使用β(2)-肾上腺素能受体的 X 射线结构进行的计算分析表明,在非激活状态下,PheVI:09(6.44)被锁定在跨膜(TM)-III 的骨架和两个疏水性残基之间,在激活时会向 TM-V 滑动约 2Å,进入由五个从 TM-III 和 TM-V 伸出的疏水性残基形成的紧密口袋。其中,位置 III:16(3.40)的残基(通常为异亮氨酸或缬氨酸)似乎充当了从非激活构象到激活构象转变的障碍或门。突变分析表明,PheVI:09 对于胃饥饿素受体 GPR119、β(2)-肾上腺素能受体和神经激肽-1 受体的组成型和/或激动剂诱导信号传导是必需的。在 ghrelin 受体中,在 TM-III 和 TM-V 之间构成疏水性口袋的四个位置中的五个位置的残基取代会损害受体信号传导。在 GPR39 中,代表缺乏位置 VI:09 处芳香族残基的 7TM 受体的 12%,尽管突变体受体的细胞表面表达减少,但观察到 LeuVI:09 的 Ala 取代后不变的激动剂诱导信号传导。结论是,PheVI:09 构成一个芳香族微开关,通过滑入 TM-III 和 TM-V 之间的紧密疏水性口袋,使 TM-VI 相对于 TM-III 稳定处于活性、向外倾斜的构象,而位置 III:16 的疏水性残基构成了此转变的门。